Skip to main content

and
  1. Article

    Open Access

    SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations

    SARS-CoV-2 variants have continuously emerged in the face of effective vaccines. Reduced neutralization against variants raises questions as to whether other antibody functions are similarly compromised, or if...

    Andrew P. Hederman, Harini Natarajan, Leo Heyndrickx in Nature Communications (2023)